Oncology PracticeStereotactic radiotherapy highly effective for brain mets in RCCNovember 30, 2018Renal Cell CarcinomaGenitourinary CancerCNS/Brain Cancer
The Journal of Community and Supportive OncologyImmunotherapy may hold the key to defeating virally associated cancersNovember 25, 2018Head & Neck/Thyroid CancersGenitourinary CancerGynecologic CancerGastroenterologyImmunotherapyLeukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell Disorders
Oncology PracticeBAP1 expression augurs prognosis of metastatic RCCNovember 19, 2018Renal Cell CarcinomaGenitourinary Cancer
Oncology PracticePD-L1 correlates with worse sporadic, hereditary ccRCC outcomesNovember 19, 2018Renal Cell CarcinomaImmuno-oncologyGenitourinary Cancer
Oncology PracticeAbiraterone also benefits low-risk metastatic prostate cancer patientsNovember 13, 2018Genitourinary Cancer
Oncology PracticeRefractory immune-mediated colitis: Fecal transplant may be the answerNovember 12, 2018Immuno-oncologyGenitourinary CancerRenal Cell CarcinomaPatient & Survivor Care
Oncology PracticeSRS beats surgery in early control of brain mets, advantage fades with timeNovember 9, 2018CNS/Brain CancerBreast CancerMelanomaGastroenterologyGenitourinary CancerRenal Cell CarcinomaGastrointestinal Cancer
Oncology PracticeCirculating tumor DNA identified by fragment sizeNovember 7, 2018Gynecologic CancerGenitourinary CancerBreast CancerRenal Cell CarcinomaCNS/Brain CancerMelanoma
Oncology PracticeTumor burden in active surveillance for mRCC may inform treatment decisionsNovember 6, 2018Renal Cell CarcinomaGenitourinary Cancer
Oncology PracticeStriking racial/ethnic differences seen in RCC featuresNovember 5, 2018Renal Cell CarcinomaGenitourinary Cancer
Oncology PracticeKPNA2 is “novel prognostic factor” in RCCNovember 2, 2018Renal Cell CarcinomaGenitourinary Cancer
Oncology PracticeATLAS: High-risk RCC patients might benefit from adjuvant axitinibOctober 31, 2018Renal Cell CarcinomaGenitourinary Cancer
The Journal of Community and Supportive OncologyNivolumab and ipilimumab combination promises new standard of care for advanced RCCOctober 28, 2018Genitourinary Cancer
Oncology PracticeSTAMPEDE: Radiation to prostate boosts survival of metastatic cancerOctober 22, 2018Genitourinary Cancer
Oncology PracticeCheckpoint inhibitor/TKI combo improves PFS of RCC over sunitinibOctober 22, 2018Renal Cell CarcinomaGenitourinary CancerImmuno-oncology
